US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Prime Medicine Inc (PRME)
Prime Medicine Inc (PRME) ニュース

PRME

Prime Medicine (PRME)

Prime Medicine Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PRME

1 2 3 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/13	21 : 00	GlobeNewswire Inc.	Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ	NASDAQ:PRME	Prime Medicine Inc
2024/05/10	21 : 22	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PRME	Prime Medicine Inc
2024/05/10	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRME	Prime Medicine Inc
2024/05/10	21 : 00	GlobeNewswire Inc.	Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates	NASDAQ:PRME	Prime Medicine Inc
2024/05/08	21 : 00	GlobeNewswire Inc.	Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)	NASDAQ:PRME	Prime Medicine Inc
2024/05/01	21 : 00	GlobeNewswire Inc.	Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference	NASDAQ:PRME	Prime Medicine Inc
2024/04/29	20 : 00	GlobeNewswire Inc.	Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)	NASDAQ:PRME	Prime Medicine Inc
2024/04/23	21 : 00	GlobeNewswire Inc.	Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings	NASDAQ:PRME	Prime Medicine Inc
2024/03/01	22 : 09	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PRME	Prime Medicine Inc
2024/03/01	22 : 04	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PRME	Prime Medicine Inc
2024/03/01	22 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRME	Prime Medicine Inc
2024/03/01	22 : 00	GlobeNewswire Inc.	Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates	NASDAQ:PRME	Prime Medicine Inc
2024/02/28	22 : 00	GlobeNewswire Inc.	Prime Medicine to Participate in Upcoming Investor Conferences	NASDAQ:PRME	Prime Medicine Inc
2024/02/24	07 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRME	Prime Medicine Inc
2024/02/24	07 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRME	Prime Medicine Inc
2024/02/23	11 : 31	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:PRME	Prime Medicine Inc
2024/02/21	07 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PRME	Prime Medicine Inc
2024/02/21	06 : 01	GlobeNewswire Inc.	Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares	NASDAQ:PRME	Prime Medicine Inc
2024/02/16	20 : 23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRME	Prime Medicine Inc
2024/02/16	20 : 17	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PRME	Prime Medicine Inc
2024/02/15	13 : 50	GlobeNewswire Inc.	Prime Medicine Announces Pricing of Upsized Public Offering	NASDAQ:PRME	Prime Medicine Inc
2024/02/15	11 : 57	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	NASDAQ:PRME	Prime Medicine Inc
2024/02/15	07 : 27	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:PRME	Prime Medicine Inc
2024/02/15	06 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRME	Prime Medicine Inc
2024/02/15	06 : 05	GlobeNewswire Inc.	Prime Medicine Announces Proposed Public Offering of Common Stock	NASDAQ:PRME	Prime Medicine Inc
2024/01/25	22 : 00	GlobeNewswire Inc.	Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis	NASDAQ:PRME	Prime Medicine Inc
2024/01/08	22 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRME	Prime Medicine Inc
2024/01/06	07 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRME	Prime Medicine Inc
2024/01/05	22 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PRME	Prime Medicine Inc
2024/01/05	22 : 00	GlobeNewswire Inc.	Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer	NASDAQ:PRME	Prime Medicine Inc

Showing the most relevant articles for your search:NASDAQ:PRME

1 2 3 次へ >>

Torrent Capital

BlackRock Utility Infras...

CAC Industrials Net Return

Lyxor MSCI Future Mobili...

Vontobel Financial Produ...

Interest Rate Hedge Port...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約